Beta Drugs Fundamentals
P/E Ratio
25.56
P/B Ratio
5.27
Div. Yield
0
Sector P/E
59.61
Sector P/B
2.6
Sec. Div. Yield
0.59
Beta Drugs Fundamentals is currently trading with a P/E Ratio of 25.56, compared to the sector average of 59.61. Its P/B Ratio stands at 5.27, while the sector’s is 2.6. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.59%.
Beta Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Beta Drugs reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
